Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treat and Extend Versus Dosing Every Eight Weeks With Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema (EVADE Study)

NCT02392364 is registered in ClinicalTrials.gov with California Retina Consultants as lead sponsor.

NCT NCT02392364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02392364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treat and Extend Versus Dosing Every Eight Weeks With Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema (EVADE Study)
Lead sponsor
California Retina Consultants
Phase
Phase 4
Overall status
Completed
Start date
April 15, 2015
Completion date
November 15, 2018
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cystoid macular edema, diabetic macular edema